Bioneer Corporation (KOSDAQ:064550)

Market Cap	259.39B -39.0%
Revenue (ttm)	330.11B +12.3%
Net Income	-2.81B
EPS	-109.00
Shares Out	25.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,023,402
Average Volume	234,496
Open	10,460
Previous Close	9,910
Day's Range	9,920 - 10,900
52-Week Range	9,050 - 17,950
Beta	n/a
RSI	46.78
Earnings Date	Apr 1, 2026

About Bioneer

Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analysis, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 064550

Financial Performance

In 2025, Bioneer's revenue was 330.11 billion, an increase of 12.29% compared to the previous year's 293.98 billion. Losses were -2.81 billion, -86.33% less than in 2024.